Finzati - Logo
LLY logo

Eli Lilly and Company

LLY • Drug Manufacturers - General
$1148.20
▼ -11.40 (-0.98%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$1.03T
Growth
8.3%
Cash Flow
4/5
Trend
Mostly stable
Evidence
Stable or improving margins · 31.7%Positive revenue growth · 25.0%Positive free cash flow · 9.99Consistent free cash flow · 4/5Healthy liquidity · 1.58
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:05 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$1,148.20
Change-0.98%
Shares Out893.70M
Market Cap$1.03T
Enterprise Value$1.07T
52W Range623.78 - 1249.45
Beta0.51
P/E38.42
P/S12.88
P/B30.29
P/FCF56.41
EV/Sales13.46

Investment DNA

How strong this company looks for long-term investors

75
out of 100
Business Quality
Margins, moat, returns
90/100
Financial Strength
Debt, cash, stability
73/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Stable or improving margins · 31.7%Positive revenue growth · 25.0%Positive free cash flow · 9.99Consistent free cash flow · 4/5Healthy liquidity · 1.58Expensive earnings multiple · 46.76

Analyst view

Analyst sentiment and price target

LLY
Analyst sentiment
Based on 45 analyst votes · 2026-09-05
83/100
Bullish
Bullish
33
Hold
9
Bearish
3
Price Target
2026-08-07
Low
$1135.00
Mean
$1336.18
Median
$1350.00
High
$1500.00

Company Overview

IPO: 6/1/1972
Industry: Drug Manufacturers - General
P/B i: 30.29
Debt / Equity i: 1.60
Operating Margin: 45.56%
Net Margin: 31.66%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 1.60
Current Ratio: 1.58
Quick Ratio: 1.19
Status: Good

Insider Transactions

Recent executive and insider activity

Seymour Melissa
Transaction: 08/01/2026
SELL
Change
-981
Price
Not reported
Filing
08/03/2026
Type
SELL
Seymour Melissa
Transaction: 08/01/2026
SELL
Change
—
Price
$1148.84
Filing
08/03/2026
Type
SELL
Alvarez Ralph
Transaction: 07/20/2026
BUY
Change
—
Price
$1146.90
Filing
07/21/2026
Type
BUY